Multihance

DRUG7 trials

Conditions

Brain PathologyBrain TumorBreast CancerCentral Nervous System DiseasesCentral Nervous System NeoplasmsCentral Nervous System PathologyPeripheral Vascular DiseaseSteno-occlusive Disease

Phase 1

A Pharmacokinetics Study of MultiHance in Pediatric Patients

CompletedNCT00411931

Bracco Diagnostics, IncCentral Nervous System Pathology

Start: 2006-09-30End: 2007-12-31Updated: 2008-01-11

Phase 3

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

CompletedNCT00408083

Bracco Diagnostics, IncPeripheral Vascular Disease

Start: 2006-12-31End: 2008-12-31Target: 100Updated: 2009-03-27

Renal MRA Crossover Study Comparing Multihance to Another Contrast Agent

CompletedNCT00415805

Bracco Diagnostics, IncSteno-occlusive Disease

Start: 2006-12-31End: 2009-02-28Updated: 2023-08-01

Multihance Versus Magnevist in Breast MRI

CompletedNCT00486473

Bracco Diagnostics, IncBreast Cancer

Start: 2007-07-31End: 2009-12-31Target: 130Updated: 2010-07-15

Phase 4

A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the Brain

CompletedNCT00323102

Bracco Diagnostics, IncBrain Pathology

Start: 2006-05-31End: 2007-03-31Target: 114Updated: 2008-01-23

Multihance at 3 Tesla (3T) in Brain Tumors

CompletedNCT00395863

Bracco Diagnostics, IncBrain Tumor

Start: 2006-11-30End: 2008-03-31Updated: 2020-11-05

Unknown Phase

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

CompletedNCT03147989

Bracco Diagnostics, IncCentral Nervous System Diseases, Central Nervous System Neoplasms

Start: 2017-05-18End: 2018-03-16Updated: 2018-07-18

Related Papers

Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).

2010-12-1641 citations